We analyzed HER2 mRNA expression by RNAscope for 41 cases of breast cancer with HER2 IHC2+, and the average HER2 signals/cell was <4.0 with a HER2/CEP17 ≥2.0. This evidence concerns the gene ERBB2 and breast carcinoma.